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Abstract
Corynebacterium urealyticum is a Gram-positive, lipophilic, multidrug resistant, and urease positive microorganism with diph-
theroid morphology. C. urealyticum causes several diseases such as urinary tract infection, chronic urological disease, urinary tract
infections, and bacteremia in immunocompromised individuals. This study reports a rare case with nosocomial infection and
hematuria caused by multidrug-resistant C. urealyticum after prostate cancer surgery.
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1. Introduction
Corynebacterium urealyticum (known as coryneform
CDC 79 group D2) is a Gram-positive, slow-growing,
multidrug-resistant, and urease positive microorganism
with a potent urease activity (1). C. urealyticum, as an op-
portunistic nosocomial pathogen, causes various diseases
such as acute cystitis, pyelonephritis, encrusted cystitis,
encrusted pyelitis, and alkaline encrusted cystitis. Infec-
tion with C. urealyticum mostly occurs in patients with
chronic urological diseases and sometimes leads to bac-
teremia (2, 3). Its strong urease activity results in promi-
nent urinary tract infections (UTIs) (4). Additionally, it
causes infrequent non-urinary infections such as pneu-
monia, peritonitis, cardiac valve infection, osteomyelitis,
postoperative wounds, and soft tissue necrosis (5). Infec-
tion byC. urealyticum is associated with several risk factors,
including prolonged hospitalization, immunodeficiency
diseases, urological procedures, and broad-spectrum an-
tibiotic therapy (1, 6, 7). We report a rare case of an 80-year-
old Iranian man who had developed nosocomial infection
and hematuria associated with multidrug-resistant C. ure-
alyticum after prostate cancer surgery.
2. Case Presentation
An 80-year-old Iranian man, who was diagnosed with
prostate cancer, was subjected to prostatectomy whose
prostate was removed and he was discharged. He was ac-
cidentally fallen at home 4 days after the operation that re-
sulted in a femur fracture. He was then hospitalized for hip
surgery. He suffered from leg edema, hematuria, and dy-
suria after 2 days of hospitalization. Initial symptoms in-
cluded chills and rapid breathing. Primary diagnosis was
venous thrombus in the deep veins of the leg (DVT) and clot
in the lungs due to pulmonary embolism. In the clinical ex-
aminations, blood pressure of 98/70 mmHg, heart rate of
72 beats/min, respiratory rate of 33 breaths/min, and body
temperature of 38˚C were recorded. The prostate-specific
antigen (PSA) level, liver enzymes, and CT chest were nor-
mal.
Treatment started with antibiotics, including
imipenem, ceftriaxone, and ciprofloxacin. He also had
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acute hematuria because of prostatectomy in addition
to receiving chemotherapy and hormone therapy. In
the emergency room, fever and the temporary loss of
consciousness associated with hematuria and acute ag-
gravation of chronic renal failure were considered due to
the relapse of the prostate cancer. Meanwhile, his temper-
ature was increasing with hematuria. The results of urine
and blood tests are shown in Table 1. Urine culture yielded
100,000 colonies/mL of Gram-positive bacilli after 4 days
of incubation, which was identified as C. urealyticum.
Table 1. Characteristic of the Patient’s Clinical and Laboratory Data
Variables Value
Characteristic of the Patient
Age, y 80
Predisposing conditions
Prostate cancer Yes
Prostatectomy Yes
DVT Yes
Prolonged hospitalization Yes
Outcome death
Recovery Yes
Laboratory Data
RBC 3.61
Hemoglobin, g/dL 9.3
HCT, % 29.5
MCV,µm3 81.7
MCH, fmol/cell 25.8
MCHC, mmol Hb/L 31.5
Platelets, /L 345000
Urea, mg/dL 21
Sodium, meq/L 139
Potassium, meq/L 4.27
Urine Analysis
Color Red
Specific gravity 1010
Glucose Negative
Ketones None
Nitrites Negative
Leukocyte esterase Negative
Clarity Cloudy
pH 8
Bilirubin Negative
Urobilirubin Negative
Blood +4
Protein Negative
RBCs Many
WBCs 6
Bacteria Many
Abbreviations: DVT, deep veins of the leg; HCT, hematocrit; RBC, red blood cells;
WBC, White blood cells.
Antimicrobial susceptibility test was conducted by
disc diffusion method on Muller Hinton blood agar and
broth microdilution with vancomycin, teicoplanin, ampi-
cillin (10 mg), cephalothin (30 mg), erythromycin (15
mg), gentamicin, imipenem (10 mg), tetracycline (30 mg),
rifampicin (5 mg), ciprofloxacin (5 mg), and ofloxacin
(5 mg) (8). Results showed that the bacterial isolate
was resistant to ceftriaxone, erythromycin, rifampicin,
ciprofloxacin, imipenem, and co-trimoxazole but sensi-
tive to vancomycin and teicoplanin. Vancomycin was pre-
scribed for 10 days and the fever subsided gradually and
the patient was then discharged. There was no recurrence
of bacteremia and hematuria during the follow-up. Writ-
ten informed consent was obtained from the patient.
3. Discussion
Corynebacteriumurealyticum is an emerging multidrug-
resistant, potentially pathogenic microorganism that
causes nosocomial and urinary tract infections in patients
with advanced and severe urological disorders. It causes
different diseases, which arise from prolonged use of a
urinary catheter, long periods of hospitalization, compro-
mised immune system, kidney transplantation, urological
procedure, chronic debilitating disease, broad-spectrum
antibiotic treatment, and cytotoxic drug usage (9). Our
results suggest that in addition to the aforementioned
factors, prostatectomy in prostate cancer should also be
considered one of the risk factors for contracting the
infection by C. urealyticum.
This patient had a long-term recovery for over 10 days,
which could be due to an improper choice of antibiotics
(ceftriaxone and imipenem) until he took vancomycin and
then his recovery was completed. Consistent with our re-
port, there was a patient who was treated by vancomycin
(1). In most cases, the majority of patients receiving suf-
ficient doses of antibiotics are cured, whereas only a few
cases of C. urealyticum (mostly with acute cystitis) are not
easily cured even when treated with multiple antibiotics.
Glycopeptides, mainly vancomycin, tetracycline, and flu-
oroquinolones are the best drugs of choice in the treat-
ment and have been used with great effects on many pa-
tients with UTIs (5). A previous study reported 6 bac-
teremic patients infected with multidrug-resistant strains
of C. urealyticum. The patients were cured with an antibi-
otic, such as vancomycin that was in vitro active against C.
urealyticum (10). In agreement with our study, the results
of several studies emphasize the emergence of multidrug-
resistant C. urealyticum with susceptibility to vancomycin
and teicoplanin as the drugs of choice.
Based on MIC results, most antibiotics are effective
in chronic, device-related, urological infections (10). A
number of studies have shown that patients with iso-
lated multidrug-resistant C. urealyticum are treated by van-
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comycin and teicoplanin (8). Many strains of C. urealyticum
have been shown to be resistant to ofloxacin, norfloxacin,
and ciprofloxacin as we found in the current study. Salem
et al. (1) demonstrated that only 20.3% of C. urealyticum iso-
lates were susceptible to ciprofloxacin. Our results showed
that our isolate was resistant to ciprofloxacin as well as
ceftriaxone. As a result, our recommendation is to stop
their prescription in multidrug-resistant bacteria. Surpris-
ingly, we then found other patients in the ward infected
by C. urealyticum proposing the ability of the microor-
ganism for cross-contamination and transmission. This
highlighted the importance of non-diphtheria corynebac-
terium species in hospital infections, particularly for clini-
cians and microbiologists. Thus accurate identification of
clinical isolates is important to determine the role of non-
diphtheria corynebacterium. It is noteworthy that pre-
senting the sign of UTIs, such as high urine pH, bladder
stones, recent urological surgeries, negative routine urine
culture, aging, and antibiotic resistance found in UTIs may
indicate the infection of C. urealyticum. In order to inhibit
bacterial transmission from infected patients, hand wash-
ing, using gloves, and avoiding unnecessary catheteriza-
tion should be applied. Diagnostic laboratories should not
ignore diphtheroid shaped microorganisms, particularly
in pure cultures of elderly and immunocompromised pa-
tient samples (10).
These bacteria should be considered common etiologi-
cal causes of nosocomial infections.In conclusion, nosoco-
mial infections are usually associated with high morbid-
ity, mortality, and financial burden. C. urealyticum is an op-
portunistic pathogen, causing different diseases, particu-
larly UTIs (11). Sufficient knowledge of emerging pathogens
and their resistance profile are critical for the treatment of
nosocomial infections (12,13).
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